T1	p 33 43	postpartum
T2	p 283 388	Department of Obstetric and Gynecology 2nd Medical Faculty Charles University and Teaching Hospital Motol
T3	p 398 454	, and Department of Obstetric and Gynecology 1st Medical
T4	p 476 492	Hospital Bulovka
T5	p 611 637	50 women with clinical and
T6	p 648 650	of
T7	i 6 19	[ Intravenous
T8	i 66 84	ferrum preparation
T9	i 136 144	safeness
T10	i 148 169	intravenous treatment
T11	i 205 223	ferrum preparation
T12	i 383 388	Motol
T13	i 485 492	Bulovka
T14	i 519 556	of sacharose ferric oxide ( Venofer )
T15	i 1341 1384	trivalent saccharose ferric oxide treatment
T16	o 120 135	effectivity and
T17	o 389 397	, Prague
T18	o 642 668	signs of postpartal anemia
T19	o 721 731	comparsion
T20	o 735 770	values of red blood count recovered
T21	o 855 913	serum values of soluble transferrin receptors and ferritin
T22	o 942 966	iron cell saturation and
T23	o 1003 1007	part
T24	o 1043 1057	adverse events
T25	o 1149 1165	pospartal anemia
T26	o 1211 1222	transfusion
T27	o 1302 1317	serious adverse